Literature DB >> 17278014

Down-regulation of iNOS and TNF-alpha expression by kaempferol via NF-kappaB inactivation in aged rat gingival tissues.

Hyung Keun Kim1, Hae Ryoun Park, Jun Sik Lee, Tae Sung Chung, Hae Young Chung, Jin Chung.   

Abstract

The primary objective of this study was to evaluate the ability and mechanism of action of kaempferol, which is contained in extracts from Nelumbo nucifera, a well-known Oriental herb used in traditional medicine, with regard to the inhibition of iNOS and TNF-alpha expression in aged rat gingival tissues. We conducted an investigation into the age-related effects of kaempferol on reactive oxygen species (ROS) and GSH oxidative status in samples of aged gingival tissues. Western blotting was conducted in order to determine the expression of iNOS, TNF-alpha, p38 MAPK, NIK/IKK, p65 and IkappaBalpha in the sample tissues. Electrophoretic mobility shift assays (EMSA) were conducted in an effort to characterize the binding activities of NF-kappaB transcription factors in the aged rat gingival nuclear extracts. Our results indicate that kaempferol reduced ROS levels and augmented GSH levels in a dose-dependent manner in the aged gingival tissues. Kaempferol was shown to effect a significant reduction in iNOS and TNF-alpha protein levels, as compared to control gingival tissue samples. The results of Western blot analysis revealed that kaempferol treatment effected the reduction of iNOS and TNF-alpha expression, decreased nuclear p65 and increased cytosolic p65, down-regulation of Erk, p38, JNK and NIK/IKK expression. The EMSA results also indicated that kaempferol, when administered to the rat tissues, attenuated the NF-kappaB nuclear binding activity. Kaempferol may inhibit ROS generation via the inhibition of iNOS and TNF-alpha expression in aged gingival tissues, via the modulation of the NF-kappaB and mitogen-activated protein kinase (MAPK) pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17278014     DOI: 10.1007/s10522-007-9083-9

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  22 in total

1.  Antidepressive effects of kaempferol mediated by reduction of oxidative stress, proinflammatory cytokines and up-regulation of AKT/β-catenin cascade.

Authors:  Wenqi Gao; Wei Wang; Yan Peng; Zhifang Deng
Journal:  Metab Brain Dis       Date:  2019-02-14       Impact factor: 3.584

2.  Kaempferol modulates pro-inflammatory NF-kappaB activation by suppressing advanced glycation endproducts-induced NADPH oxidase.

Authors:  Ji Min Kim; Eun Kyeong Lee; Dae Hyun Kim; Byung Pal Yu; Hae Young Chung
Journal:  Age (Dordr)       Date:  2010-01-13

3.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

4.  Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity.

Authors:  Kyung Mi Lee; Ki Won Lee; Sung Keun Jung; Eun Jung Lee; Yong-Seok Heo; Ann M Bode; Ronald A Lubet; Hyong Joo Lee; Zigang Dong
Journal:  Biochem Pharmacol       Date:  2010-07-01       Impact factor: 5.858

5.  Kaempferol acts through mitogen-activated protein kinases and protein kinase B/AKT to elicit protection in a model of neuroinflammation in BV2 microglial cells.

Authors:  S E Park; K Sapkota; S Kim; H Kim; S J Kim
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  Protective effects of kaempferol on lipopolysaccharide-induced mastitis in mice.

Authors:  Rongfeng Cao; Kaiqiang Fu; Xiaopei Lv; Weishi Li; Naisheng Zhang
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

7.  Transcriptional profiling in human HaCaT keratinocytes in response to kaempferol and identification of potential transcription factors for regulating differential gene expression.

Authors:  Byung Young Kang; Sujong Kim; Ki-Hwan Lee; Yong Sung Lee; Il Hong; Mi-Ock Lee; Daejin Min; Ihseop Chang; Jae Sung Hwang; Jun Seong Park; Duck Hee Kim; Byung-gee Kim
Journal:  Exp Mol Med       Date:  2008-04-30       Impact factor: 8.718

8.  Kaempferol inhibits IL-1β-stimulated, RANKL-mediated osteoclastogenesis via downregulation of MAPKs, c-Fos, and NFATc1.

Authors:  Won-Seok Lee; Eun-Gyeong Lee; Myung-Soon Sung; Wan-Hee Yoo
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

9.  Regulation of Proinflammatory Mediators via NF-κB and p38 MAPK-Dependent Mechanisms in RAW 264.7 Macrophages by Polyphenol Components Isolated from Korea Lonicera japonica THUNB.

Authors:  Kwang-Il Park; Sang-Rim Kang; Hyeon-Soo Park; Do Hoon Lee; Arulkumar Nagappan; Jin A Kim; Sung Chul Shin; Eun Hee Kim; Won Sup Lee; Hyon-Jong Chung; Su Jin An; Gon Sup Kim
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-07       Impact factor: 2.629

10.  Systems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCM.

Authors:  Yonghua Wang; Chunli Zheng; Chao Huang; Yan Li; Xuetong Chen; Ziyin Wu; Zhenzhong Wang; Wei Xiao; Boli Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.